CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-02 | PAKOLA STEVE Chief Medical Officer | Sale 10b5-1 | −2,161 | $13.64 | $29K | 213,009 |
| 2026-07-01 | PAKOLA STEVE Chief Medical Officer | Sale | −36,725 | $12.86 | $472K | 213,009 |
| 2026-06-29 | PAKOLA STEVE Chief Medical Officer | Sale | −19,608 | $11.04 | $216K | 213,009 |
| 2026-05-11 | PAKOLA STEVE Chief Medical Officer | Sale 10b5-1 | −15,309 | $11.02 | $169K | 232,617 |
| 2026-03-10 | PAKOLA STEVE Chief Medical Officer | Sale 10b5-1 | −5,124 | $10.35 | $53K | 247,926 |
| 2025-10-09 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −20,811 | $12.62 | $263K | 216,162 |
| 2025-09-29 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −7,624 | $10.03 | $76K | 236,973 |
| 2025-09-10 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −7,734 | $10.02 | $77K | 244,597 |
| 2025-05-12 | Mills Kenneth T. Director | Sale 10b5-1 | −20,602 | $7.91 | $163K | 475,103 |
| 2024-10-01 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −10,000 | $10.11 | $101K | 11,286 |
| 2024-09-03 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −9,300 | $11.50 | $107K | 11,986 |
| 2024-09-03 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −700 | $12.34 | $9K | 11,286 |
| 2024-08-01 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −9,600 | $13.45 | $129K | 11,786 |
| 2024-08-01 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −400 | $14.59 | $6K | 11,386 |
| 2024-08-01 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −100 | $15.00 | $2K | 11,286 |
| 2024-08-01 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −100 | $15.00 | $2K | 170,037 |
| 2024-07-29 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −11,000 | $15.05 | $165K | 11,286 |
| 2024-07-29 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −9,648 | $15.04 | $145K | 170,137 |
| 2024-07-25 | Mills Kenneth T. Director | Sale 10b5-1 | −15,369 | $13.96 | $215K | 408,035 |
| 2024-07-24 | Mills Kenneth T. Director | Sale 10b5-1 | −12,221 | $13.78 | $168K | 408,035 |
Page 1 of 2 · 32 trades